1 of 1
HOUSE DOCKET, NO. 2123 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 1082
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Bruce J. Ayers
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to enact the pharmacy benefit manager compensation reform.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:Bruce J. Ayers1st Norfolk1/15/2025 1 of 9
HOUSE DOCKET, NO. 2123 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 1082
By Representative Ayers of Quincy, a petition (accompanied by bill, House, No. 1082) of Bruce
J. Ayers relative to pharmacy benefit manager insurance compensation reform. Financial
Services.
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 934 OF 2023-2024.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act to enact the pharmacy benefit manager compensation reform.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 The General Laws are hereby amended by inserting after Chapter 175M following new
2chapter:
3 CHAPTER 175N. Pharmacy Benefit Manager Compensation Reform Act of 2022
4 Section 1. Definitions
5 As used in this chapter, the following words shall, unless the context clearly requires
6otherwise, have the following meanings:—
7 “Carrier”, any health insurance issuer that is subject to state law regulating insurance and
8offers health insurance coverage, as defined in 42 U.S.C. § 300gg-91, or any state or local
9governmental employer plan. 2 of 9
10 “Commissioner”, the commissioner of insurance.
11 “Division”, the division of insurance.
12 “Enrollee”, any individual entitled to coverage of health care services from a carrier.
13 “Health benefit plan”, a policy, contract, certificate or agreement entered into, offered or
14issued by a carrier to provide, deliver, arrange for, pay for, or reimburse any of the costs of
15health care services.
16 “Person”, a natural person, corporation, mutual company, unincorporated association,
17partnership, joint venture, limited liability company, trust, estate, foundation, not-for-profit
18corporation, unincorporated organization, government or governmental subdivision or agency.
19 “Pharmacy benefit management fee”, a fee that covers the cost of providing one or more
20pharmacy benefit management services and that does not exceed the value of the service or
21services actually performed by the pharmacy benefit manager.
22 “Pharmacy benefit management service”:
23 (i) Negotiating the price of prescription drugs, including negotiating and contracting for
24direct or indirect rebates, discounts, or other price concessions.
25 (ii) Managing any aspect(s) of a prescription drug benefit, including but not limited to,
26the processing and payment of claims for prescription drugs, the performance of utilization
27review, the processing of drug prior authorization requests, the adjudication of appeals or
28grievances related to the prescription drug benefit, contracting with network pharmacies,
29controlling the cost of covered prescription drugs, managing data relating to the prescription drug
30benefit, or the provision of services related thereto. 3 of 9
31 (iii) Performing any administrative, managerial, clinical, pricing, financial,
32reimbursement, data administration or reporting, or billing service; and
33 (vii) Such other services as the commissioner may define in regulation.
34 “Pharmacy benefit manager”, any person that, pursuant to a written agreement with a
35carrier or health benefit plan, either directly or indirectly, provides one or more pharmacy benefit
36management services on behalf of the carrier or health benefit plan, and any agent, contractor,
37intermediary, affiliate, subsidiary, or related entity of such person who facilitates, provides,
38directs, or oversees the provision of the pharmacy benefit management services.
39 “Pharmacy benefit manager duty”, a duty and obligation to perform pharmacy benefit
40management services with care, skill, prudence, diligence, fairness, transparency, and
41professionalism, and for the best interests of the enrollee, the health benefit plan, and the
42provider, as consistent with the requirements of this section and any regulations that may be
43adopted to implement this chapter.
44 “Price protection rebate”, a negotiated price concession that accrues directly or indirectly
45to the carrier or health benefit plan, or other party on behalf of the carrier or health benefit plan,
46including a pharmacy benefit manager, in the event of an increase in the wholesale acquisition
47cost of a drug above a specified threshold.
48 “Provider”, an individual or entity that provides, dispenses, or administers one or more
49units of a prescription drug.
50 “Related entity”: 4 of 9
51 (i) any entity, whether foreign or domestic, that is a member of any controlled group of
52corporations (as defined in section 1563(a) of the Internal Revenue Code, except that “50
53percent” shall be substituted for “80 percent” wherever the latter percentage appears in such
54code) of which a pharmacy benefit manager is a member; or
55 (ii) any of the following persons or entities that are treated as a related entity to the extent
56provided in rules adopted by the commissioner:
57 (A) a person other than a corporation that is treated under such rules as a related entity of
58a pharmacy benefit manager, or
59 (B) a person or entity that is treated under such rules as affiliated with a pharmacy benefit
60manager in cases where the pharmacy benefit manager is a person other than a corporation.
61 “Rebate”:
62 (i) Negotiated price concessions including but not limited to base price concessions
63(whether described as a “rebate” or otherwise) and reasonable estimates of any price protection
64rebates and performance-based price concessions that may accrue directly or indirectly to the
65carrier or health benefit plan, or other party on behalf of the carrier or health benefit plan,
66including a pharmacy benefit manager, during the coverage year from a manufacturer,
67dispensing pharmacy, or other party in connection with the dispensing or administration of a
68prescription drug, and
69 (ii) Reasonable estimates of any negotiated price concessions, fees and other
70administrative costs that are passed through, or are reasonably anticipated to be passed through,
71to the carrier or health benefit plan, or other party on behalf of the carrier or health benefit plan, 5 of 9
72including a pharmacy benefit manager, and serve to reduce the carrier or health benefit plan’s
73liabilities for a prescription drug.
74 “Spread pricing”, any amount charged or claimed by a pharmacy benefit manager in
75excess of the ingredient cost for a dispensed prescription drug plus dispensing fee paid directly
76or indirectly to any pharmacy, pharmacist, or other provider on behalf of the health benefit plan,
77less a pharmacy benefit management fee.
78 “Unaffiliated pharmacy”, any dispensing pharmacy that is not fractionally or wholly
79owned by, or a subsidiary or an affiliate of, a pharmacy benefit manager.
80 Section 2. Compensation and Prohibition on Spread Pricing
81 (a) No pharmacy benefit manager may derive income from pharmacy benefit
82management services provided to a carrier or health benefit plan in this state except for income
83derived from a pharmacy benefit management fee. The amount of any pharmacy benefit
84management fees must be set forth in the agreement between the pharmacy benefit manager and
85the carrier or health benefit plan.
86 (b) The pharmacy benefit management fee charged by or paid to a pharmacy benefit
87manager from a carrier or health benefit plan shall not be directly or indirectly based or
88contingent upon:
89 (1) the acquisition cost or any other price metric of a drug;
90 (2) the amount of savings, rebates, or other fees charged, realized, or collected by or
91generated based on the activity of the pharmacy benefit manager; or 6 of 9
92 (3) the amount of premiums, deductibles, or other cost sharing or fees charged, realized,
93or collected by the pharmacy benefit manager from patients or other persons on behalf of a
94patient.
95 (c) Annually by December 31, each pharmacy benefit manager operating in the state must
96certify to the commissioner that it has fully and completely complied with the requirements of
97this section throughout the prior calendar year. Such certification must be signed by the chief
98executive officer or chief financial officer of the pharmacy benefit manager.
99 (d) No pharmacy benefit manager, carrier, or health benefit plan may, either directly or
100through an intermediary, agent, or affiliate engage in, facilitate, or enter into a contract with
101another person involving spread pricing in this state.
102 (e) A pharmacy benefit manager contract with a carrier or health benefit plan entered
103into, renewed, or amended on or after the effective date this act must:
104 (1) Specify all forms of revenue, including pharmacy benefit management fees, to be paid
105by the carrier or health benefit plan to the pharmacy benefit manager; and
106 (2) Acknowledge that spread pricing is not permitted in accordance with this section.
107 Section 3. Audits of Pharmacy Benefit Managers
108 (a) The commissioner and any carrier or health benefit plan contracted with a pharmacy
109benefit manager holding a license issued by the division may audit the pharmacy benefit
110manager once per calendar year. This audit right is in addition to, and shall not be construed to
111limit, any other audit rights authorized by law or contract. As part of any such audit, the 7 of 9
112commissioner, carrier, or health benefit plan may request information including but not limited
113to the following:
114 (1) All reimbursement paid to retail pharmacies, on a claim level, for all customers of the
115pharmacy benefit manager in the state, including drug-specific reimbursement, dispensing fees,
116all rebates, other fees, ancillary charges, clawbacks, or adjustments to reimbursement;
117 (2) Any difference in reimbursement paid to affiliated pharmacies and unaffiliated
118pharmacies, including differences in reimbursed ingredient costs and dispensing fees;
119 (3) Historical claims data including ingredient cost, quantity, dispensing fee, sales tax,
120usual & customary price, channel (mail/retail), carrier or health benefit plan paid amount, days’
121supply, the amount paid by the covered individual, formulary tier, acquisition cost, and any
122administrative fee associated with the claim, as applicable; and
123 (4) Aggregate rebate amounts received directly or indirectly from manufacturers
124(including from any other entity affiliated with or related to the pharmacy benefit manager that
125negotiates or contracts with manufacturers, such as group purchasing organizations and rebate
126aggregators) by calendar quarter.
127 (b) The pharmacy benefit manager shall provide information referenced in subsection (a)
128within thirty (30) days of its receipt of any request from the commissioner, carrier, or health
129benefit plan.
130 (c) The commissioner may dictate the form in which the pharmacy benefit manager will
131provide information in response to an audit under subsection (a). 8 of 9
132 (d) The pharmacy benefit manager must certify that all information submitted to the
133commissioner, or any carrier or health benefit plan in accordance with this section is accurate
134and complete in all material respects. Such certification must be signed by the chief executive
135officer or chief financial officer of the pharmacy benefit manager.
136 (e) The commissioner and any carrier or health benefit plan contracted with a pharmacy
137benefit manager holding a license issued by the division shall not directly or indirectly publish or
138otherwise disclose any confidential, proprietary information, including but not limited to any
139information that would reveal the identity of a specific health benefit plan or manufacturer, the
140price(s) charged for a specific drug or class of drugs, the amount of any rebates provided for a
141specific drug or class of drugs, or that would otherwise have the potential to compromise the
142financial, competitive, or proprietary nature of the information. Such information shall be
143considered to be a trade secret and confidential commercial information, shall not be considered
144a public record, within the meaning of chapter sixty-six of the General Laws, and shall not be
145disclosed directly or indirectly, or in a manner that would allow for the identification of an
146individual product, therapeutic class of products, or manufacturer, or in a manner that would
147have the potential to compromise the financial, competitive, or proprietary nature of the
148information. The commissioner and any carrier or health benefit plan contracted with a pharmacy
149benefit manager holding a license issued by the division shall impose the confidentiality
150protections of this subsection on any vendor or downstream third party that may receive or have
151access to this information.
152 Section 4. Savings Clause 9 of 9
153 (a) In implementing the requirements of this Act, the state shall only regulate a pharmacy
154benefit manager, carrier, or health benefit plan to the extent permissible under applicable law.
155 (b) If any section, provision, or portion of this Act, including any condition or
156prerequisite to any action or determination thereunder, is for any reason held to be illegal or
157invalid, this illegality or invalidity shall not affect the remainder thereof or any other section,
158provision, or portion of this Act, including any condition or prerequisite to any action or
159determination thereunder, which shall be construed and enforced and applied as if such illegal or
160invalid portion were not contained therein.
161 Section 5. Penalties
162 (a) If the commissioner determines that a pharmacy benefit manager is in violation of this
163chapter or any rule or regulation promulgated under this chapter, the commissioner shall issue a
164monetary penalty, suspend or revoke the pharmacy benefit manager’s license or take other action
165that the commissioner deems necessary.
166 (b) The commissioner shall issue rules and regulations to establish a process for
167administrative appeal of any penalty, suspension or revocation imposed in accordance with this
168section.
169 Section 6. Rules
170 The commissioner shall adopt any written policies, procedures or regulations the
171commissioner determines necessary to implement this section.